Shkreli is planning to step down from Turing, and it has not yet been decided whether his replacement will serve in an interim or permanent capacity, the report said, citing people familiar with the matter.
Shkreli was charged in a federal indictment on Thursday related to his time managing hedge fund MSMB Capital Management and CEO of biopharmaceutical company Retrophin IncTuring Pharma close to replacing CEO Shkreli: WSJ
Carlo Allegri
TOP READS FROM THE FISCAL TIMES
-
Lawsuit saying Twitter aided Islamic State thrown out by U.S. appeals court
(Reuters) - A federal appeals court in San Francisco ruled on Wednesday that Twitter Inc is not liable to families of... -
Boeing ends Wall St.'s slide, Fed caution limits gains
(Reuters) - A surge in Boeing led Wall Street out of a two-day slump on Wednesday, but U.S. stocks pared gains in early... -
U.S. food distributors allege Tyson Foods, rivals fixed chicken prices
CHICAGO (Reuters) - Top U.S. food distributors Sysco Corp and U.S. Foods Inc have sued the country's biggest chicken...